Neuralstem NSI-566/ALS Principal Investigator at 48th Annual Canadian Neurological Sciences Federation Congress 2013

Speaker: Eva Feldman, MD, PhD
Additional Information: Eva Feldman, MD, PhD, principal investigator and Director of the A. Alfred Taubman Medical Research Institute and Director of Research of the ALS Clinic at the University of Michigan Health System, will present results from the NSI-566/ALS Phase I trial from all 15 patients, including new data from the cervical cohorts. Dr. Feldman’s is the first presentation (CSCN Gloor Lecture) of the Grand Plenary, a multi-disciplinary guest lecture series for Congress Delegates. 
48th Annual Canadian Neurological Sciences Federation Congress 2013 

Montreal, Quebec